tetrandrine has been researched along with Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 6 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Shao, L; Wang, S; Zhang, H | 1 |
| Cui, JR; Du, GH; Fang, LH; Feng, XE; Li, QS; Shi, L | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Bhagya, N; Chandrashekar, KR | 1 |
| Guo, L; Guo, YP; Guo, YR; Liu, YS; Song, JW; Zhong, WX | 1 |
| Deng, X; Li, X; Qin, Z; Song, Y; Xu, Q; Yang, J; Yuan, Q | 1 |
| Lan, JJ; Li, YJ; Liao, SG; Liu, JL; Pan, WD; Wang, L; Wang, S; Wang, YL; Xu, GB; Zhang, H; Zhang, RH; Zhao, YL; Zhou, M; Zhou, YH | 1 |
| He, X; Luan, F; Zeng, N | 1 |
| He, D; Hong, M; Li, J; Liu, Y; Sun, B; Wang, J; Wen, W | 1 |
| K R, C; N, B | 1 |
| Chen, Y; Li, P; Tong, N; Yang, S; Zhang, J; Zhao, X | 1 |
| Ai, J; Gong, Y; Guan, R; Guo, Y; He, W; Qiu, W; Ren, Y; Su, M; Xie, F; Zhang, J | 1 |
| Li, W; Liu, T; Liu, X | 1 |
| Parak, WJ; Pelaz, B; Schneider, M; Shi, C; Thum, C; Tu, W; Zhang, Q; Zhang, Y | 1 |
| Ding, Y; Guo, W; Hu, Y; Jiang, X; Li, R; Liu, B; Liu, Q; Qian, X; Xie, L; Yu, L; Zhu, Z | 1 |
| Chen, G; Han, X; Iadecola, C; Ma, D; Meng, L; Song, X; Wang, F; Wang, G; Wang, S; Weng, D; Xi, L; Xing, H; Xu, G; Yao, W; Zhou, J; Zhu, T | 1 |
6 review(s) available for tetrandrine and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Autophagy and cancer: Can tetrandrine be a potent anticancer drug in the near future?
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Mammals; Neoplasms | 2022 |
Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Biological Availability; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Neoplasms | 2020 |
Traditional Chinese medicines and their active ingredients sensitize cancer cells to TRAIL-induced apoptosis.
Topics: Apoptosis; Benzylisoquinolines; Clematis; Diterpenes; Humans; Isoflavones; Medicine, Chinese Traditional; Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2021 |
Tetrandrine and cancer - An overview on the molecular approach.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasms; Signal Transduction | 2018 |
Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzylisoquinolines; Cell Movement; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Plant Roots; Stephania | 2016 |
10 other study(ies) available for tetrandrine and Neoplasms
| Article | Year |
|---|---|
CHMIS-C: a comprehensive herbal medicine information system for cancer.
Topics: Antineoplastic Agents, Phytogenic; Databases, Factual; Internet; National Institutes of Health (U.S.); Neoplasms; Phytotherapy; Plant Preparations; United States; United States Food and Drug Administration | 2005 |
Synthesis and biological activity of flavanone derivatives.
Topics: Antineoplastic Agents; Atherosclerosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Endothelial Cells; Flavanones; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neoplasms; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2010 |
Nano-Liposomes Double Loaded with Curcumin and Tetrandrine: Preparation, Characterization, Hepatotoxicity and Anti-Tumor Effects.
Topics: Animals; Benzylisoquinolines; Chemical and Drug Induced Liver Injury; Curcumin; Drug Carriers; Liposomes; Neoplasms; Particle Size; Zebrafish | 2022 |
Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer.
Topics: Disulfides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HeLa Cells; Humans; Nanoparticles; Neoplasms; Paclitaxel; Polymers; Prodrugs; Reactive Oxygen Species | 2023 |
Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cell Line, Tumor; Cell Movement; Human Umbilical Vein Endothelial Cells; Humans; Neoplasm Invasiveness; Neoplasms | 2020 |
Tetrandrine enhances the anticancer effects of arsenic trioxide in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Benzylisoquinolines; Cell Cycle Checkpoints; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; HeLa Cells; Hep G2 Cells; Humans; Necrosis; Neoplasms; Oxides; Time Factors | 2014 |
Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Benzylisoquinolines; Caspase 3; Citric Acid Cycle; Energy Metabolism; Female; Glucose; HeLa Cells; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Neoplasms; Oxidative Phosphorylation; RNA Interference; Sequestosome-1 Protein; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Inhibition of the cancer-associated TASK 3 channels by magnetically induced thermal release of Tetrandrine from a polymeric drug carrier.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Drug Carriers; Drug Delivery Systems; Hot Temperature; Humans; Lactic Acid; Magnetite Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Potassium Channels, Tandem Pore Domain; Xenopus | 2016 |
Reversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred ICR; Nanoparticles; Neoplasms; Neoplasms, Experimental; Polyesters; Polyethylene Glycols; Survival Analysis; Tumor Burden | 2011 |
Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis.
Topics: 4-Aminopyridine; Alkaloids; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Calcium Channel Blockers; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA Fragmentation; DNA-Binding Proteins; Glyburide; Heat-Shock Proteins; Humans; Large-Conductance Calcium-Activated Potassium Channels; Neoplasms; Oncogene Proteins, Viral; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Tetraethylammonium; Tumor Suppressor Protein p53 | 2007 |